Abstract
In this study, we examined injury progression after intracerebral haemorrhage (ICH) induced by collagenase in mice using a preclinical 11.7 Tesla MRI system. On T2-weighted MRI, lesion and striatal volumes were increased on day 3 and then decreased from days 7 to 28. On day 3, with an increase in striatal water content, vasogenic oedema in the perihaematomal region presented as increased T2 and increased apparent diffusion coefficient (ADC) signal. With a synchronous change in T2 and ADC signals, microglial activation peaked on day 3 in the same region and decreased over time. Iron deposition appeared on day 3 around the haematoma border but did not change synchronously with ADC signals. Vascular permeability measured by Evans blue extravasation on days 1, 3, and 7 correlated with the T1-gadolinium results, both of which peaked on day 3. On diffusion tensor imaging, white matter injury was prominent in the corpus callosum and internal capsule on day 3 and then partially recovered over time. Our results indicate that the evolution of grey/white matter injury and blood-brain barrier disruption after ICH can be assessed with multimodal MRI, and that perihaematomal vasogenic oedema might be attributable to microglial activation, iron deposition, and blood-brain barrier breakdown.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Introduction
Spontaneous intracerebral haemorrhage (ICH) remains a significant cause of morbidity and mortality throughout the world1. Its mortality increases from 40% at 1 month to 54% at 1 year2. However, interventions for ICH are very limited. Therefore, understanding the mechanisms of ICH pathology and repair and identifying potential treatments have high priorities.
Advances in imaging options, especially in magnetic resonance imaging (MRI), have resulted in improved management and prognostication of ICH3. T2-weighted (T2wt) MRI is used to define the area of blood clot in the haemorrhagic lesion4; T1-gadolium (T1-Gd) enhancement MRI can detect the presence of blood-brain barrier (BBB) disruption5; apparent diffusion coefficient (ADC) can be used to evaluate cytotoxic and vasogenic oedema6,7; and diffusion tensor imaging (DTI) allows for quantitative evaluation of the structural integrity of white matter tracts, which can predict motor recovery8,9.
Preclinical ICH models have greatly improved our knowledge of the pathophysiology of ICH and have been a valuable tool for testing potential therapeutic strategies. In particular, transgenic mouse models are helpful for addressing genetic influences on early brain injury and late brain repair after ICH10. As one of the two most commonly used ICH models, collagenase injection is a simple and reproducible procedure that lacks the drawbacks associated with the blood injection model such as variable lesion size caused by backflow of the injected blood along the needle track10,11,12. Furthermore, in contrast to the blood ICH model, the collagenase model mimics an acute cerebrovascular rupture and BBB breakdown and imitates haematoma expansion13 similar to that present in ICH patients10,12. The blood ICH model has advantages for investigating the mechanisms of blood clot toxicity.
Because elucidating pathogenic mechanisms and testing potential therapies are the focus of current preclinical ICH research, it is important to use clinically relevant MRI parameters to assess the evolution of ICH-induced brain damage and repair in the same subject. In recent studies, investigators have reported MRI-assessed lesion volume and brain tissue loss by T2wt MRI14,15,16, brain oedema volume by ADC17, white matter injury by DTI18,19, and BBB disruption by T1-Gd MRI20, mostly in rats. None of the studies has used multimodality MRI to assess the grey and white matter injury and repair, perihaematomal oedema, or BBB disruption over time in a mouse ICH model. In this study, we used T2wt MRI, T1-Gd MRI, and DTI to investigate corresponding changes in brain structure on days 3, 7, and 28 in a collagenase-induced mouse model of ICH. We also compared these MRI features to histologic changes and investigated the correlation between MRI findings and neurologic deficits.
Results
Changes in haematomal lesion volume on T2wt MRI and histology
Haematomal lesion volume was manually delineated and measured in T2wt MRI and cresyl violet (CV)-stained brain sections. At day 3, T2wt MRI showed that the lesions contained a region with high signal intensities surrounded by dark rims. The signal in the high-intensity region was significantly reduced on days 7 and 28 (Fig. 1a). On the CV-stained brain sections, lesions or dead tissues were identified by lack of staining on days 3 and 7, and a fibrous scar was identified on day 28 (Fig. 1a). Adjacent fresh brain sections showed that the haematoma in the striatum resolved over the course of 28 days (Fig. 1a). Both T2wt MRI and CV staining showed a progressive decrease in relative lesion volume (percent of contralateral hemisphere; day 3: 6.7 ± 3.3% and 6.5 ± 2.6%; day 7: 1.9 ± 1.4% and 1.6 ± 0.9%; day 28: 1.3 ± 0.4% and 1.2 ± 0.4%; Fig. 1b,c).
Volumetric changes after ICH
Based on T2wt MRI, we obtained the volumes of major structures in the ICH brain via segmentation (Fig. 2a,b). The relative volume of the ipsilateral striatum (percent of contralateral hemisphere) increased significantly from 13.1 ± 1.2% pre-ICH to 25.9 ± 2.7% at 3 days post-ICH and then decreased to 16.8 ± 4.8% at 7 days and 10.3 ± 1.8% at 28 days (all P < 0.001 vs. pre-ICH; Fig. 2e, top panel). These changes paralleled the changes in CV staining at the corresponding time points (pre-ICH, 13.4 ± 1.2%; day 3, 24 ± 2.8%; day 7, 16.4 ± 2.8%; and day 28, 9.4 ± 1%; all P < 0.05 vs. pre-ICH; Fig. 2e, bottom panel). The ipsilateral ventricular volume decreased from 3.20 ± 0.4% pre-ICH to 2.81 ± 1.2% at 3 days and then increased to 3.62 ± 0.8% at 7 days and 4.39 ± 1% at 28 days (P < 0.05; Fig. 2c,d; Fig. 2f, top), again paralleled by changes in CV staining (2.6 ± 1.2%, 1.8 ± 0.2%, 3.2 ± 0.8%, and 4.0 ± 0.8%) at the respective time points (Fig. 2f, bottom). The post hoc test showed that ventricular volume at day 28 was significantly larger than that pre-ICH (P = 0.011), whereas striatal volume was significantly reduced at that time point (P = 0.04). The tissue loss in the ipsilateral parenchyma showed significant reduction at day 3 (90.8 ± 2.3%), day 7 (93.8 ± 1.2%), and day 28 (94.9 ± 1.5%) compared to pre-ICH (97.4 ± 0.9%; P < 0.001; Fig. 2g, top) and was paralleled by changes in CV staining at the corresponding time points (91.5 ± 1.5%, 94.8 ± 1.6%, 95.9 ± 1.2%, and 98.4 ± 1%; Fig. 2g, bottom). We also found significantly decreased volume in the ipsilateral cortex at day 28 compared with that pre-ICH on T2wt MRI but no changes in CV staining. There was no change in hippocampal volumes by either MRI or CV staining (See Supplementary Fig. S1).
Perihaematomal oedema
Tissue ADC estimated from diffusion MRI measurements has traditionally been used to detect cytotoxic and vasogenic oedema after stroke. Cytotoxic oedema represents the redistribution of water from extracellular to intracellular compartments, without a change in local constituents; therefore, MRI T1 and T2 signal intensity should not change markedly. Because cytotoxic oedema with minimum changes in T2 signal and large decreases in ADC signal cannot be detected on days 3 and 7 in our model, we quantified the volume of vasogenic oedema in the perihaematomal region with high T2 and high ADC signal21 (Fig. 3a, arrows). We used the ratio of values in the perihaematomal region to values in the corresponding contralateral brain region (Fig. 3a, red circle) on T2 or ADC images to show how the signal changed from the pre-ICH time point to days 3 and 7 post-ICH. The ratio of T2 values in the perihaematomal region was increased significantly at day 3 and then decreased at day 7 compared to that at baseline (0.99 ± 0.06, 1.19 ± 0.22, and 0.75 ± 0.08 at baseline, day 3, and day 7, respectively, P < 0.001 on day 3; Fig. 3b). The ratio of ADC values in the perihaematomal region was significantly higher at day 3 but decreased to the baseline level at day 7, compared to that at pre-ICH (0.96 ± 0.07, 1.22 ± 0.09, and 0.94 ± 0.03 at baseline, day 3, and day 7, respectively, P < 0.001 on day 3; Fig. 3c). Measurements of brain oedema showed that brain water content in the ipsilateral striatum increased significantly from 78.7 ± 1.4% at pre-ICH to 81.7 ± 3.1% on day 3 (P = 0.026), and returned to baseline at days 7 (78.4 ± 2.0%) and 28 (78.5 ± 1.6%). The volume of perihaematomal regions with hyperintense ADC signals indicative of vasogenic oedema decreased from day 3 (7.36 ± 2.55 mm3) to day 7 (0.37 ± 0.34 mm3, P < 0.001; Fig. 3d). In comparison, the contralateral striatum, ipsilateral cortex, and contralateral cortex showed no significant change in tissue water content during the same time period (Fig. 3e,f), suggesting that brain oedema increases transiently in the ipsilateral striatum at day 3.
T2 and ADC signals change in both lesion and perilesional areas
In addition to clearly defined brain regions with perihaematomal vasogenic oedema, the unique signatures in MRI signals, combined with T2 and ADC signals, identified another four brain regions associated with the lesion that may experience different pathologic states. These regions include lesion core, lesion edge, perihaematomal region, and oedema edge (see Supplementary Fig. S2a). We used the ratio of values in these four areas to that in the contralateral brain tissue on T2 or ADC images to show the change in signals before ICH and at days 3 and 7. In the lesion core, the ratio of T2 value was elevated at day 3 and decreased at day 7, but at both time points, it was higher than the pre-ICH value (0.99 ± 0.06, 2.12 ± 0.62, and 1.57 ± 0.34 at baseline, day 3, and day 7, respectively, all P < 0.05). The ratio of ADC value decreased significantly from day 3 to day 7 compared to that at pre-ICH (0.96 ± 0.06, 0.66 ± 0.02, and 0.52 ± 0.1 at baseline, day 3, and day 7, respectively, all P < 0.05) (see Supplementary Fig. S2b). At lesion edge, the ratio of both T2 and ADC value decreased significantly from day 3 to day 7 compared with that at pre-ICH (T2: 0.99 ± 0.06, 0.78 ± 0.1, and 0.42 ± 0.18 at baseline, day 3, and day 7, respectively, all P < 0.05; ADC: 0.96 ± 0.07, 0.73 ± 0.21, and 0.53 ± 0.09, respectively, all P < 0.05; Supplementary Fig. S2c). The quantification of the signal change in the perihaematomal region (vasogenic oedema with high T2 and high ADC signals, Supplementary Fig. S2d) is shown in Fig. 3a–d. At oedema edge, the ratio of T2 value did not change at day 3 but decreased at day 7 compared to that at pre-ICH (0.99 ± 0.06, 0.94 ± 0.08, and 0.83 ± 0.05 at baseline, day 3, and day 7, respectively, P = 0.001). The ratio of ADC value increased significantly at day 3 but decreased at day 7 compared to that at pre-ICH (0.96 ± 0.07, 1.05 ± 0.06, and 0.97 ± 0.02 at baseline, day 3, and day 7, respectively, P = 0.01; see Supplementary Fig. S2e).
Perihaematomal inflammation
Activated microglia positive for Iba-1 significantly increased after ICH (indicative of neuroinflammation), especially in the perihaematomal region on day 3. The area with increased Iba-1 signal intensity approximately corresponded to the regions with hyperintense ADC signals (Fig. 4a, first and second rows). The number of activated microglia increased around the lesion at 3 days and then decreased at 7 and 28 days (28 ± 7/0.1 mm2, 93 ± 9/0.1 mm2, 76 ± 12/0.1 mm2, and 75 ± 14/0.1 mm2 for sham and at days 3, 7, and 28 post-ICH, respectively, all P < 0.05 vs. sham, Fig. 4a second row and b). The number of GFAP-positive cells progressively increased from day 3 to day 28, compared with that in sham animals (11 ± 0.8/0.1 mm2, 30 ± 38/0.1 mm2, 58 ± 30/0.1 mm2, and 146 ± 21/0.1 mm2 for sham and days 3, 7, and 28 post-ICH, respectively, all P < 0.05, Fig. 4a second row and c). Perls’ staining (indicative of iron deposition) showed large numbers of iron-positive cells along the inner border of the haematoma at days 3 and 7; most appeared to be activated microglia/macrophages, based on cell morphology (Fig. 4a third and fourth row). Quantification analysis showed that the iron-positive area increased significantly after ICH compared with that of the sham group (3.4 ± 1.8%, 20.4 ± 3.0%, 23.6 ± 4.1%, and 13.8 ± 2.6% for sham and days 3, 7, and 28 post-ICH, respectively, P = 0.02, Fig. 4d). These results indicate that glial response, especially microglia/macrophage activation and iron deposition, may play a role in the formation of perihaematomal oedema.
BBB disruption
We estimated BBB breakdown by both gadolinium-enhanced T1-MRI (T1-Gd MRI) and Evans blue staining. In T1-Gd MRI, the signal intensity increased from day 1 (14.5 ± 4.7 with respect to signals from the contralateral side) to day 3 (40.3 ± 7.9), and then decreased progressively from day 3 to days 7 and 11 (8.4 ± 2.3 and 1.4 ± 1.3, respectively, both P < 0.05 vs. day 3; Fig. 5a,b). No apparent enhancement was visible on days 11 and 28, indicating that BBB recovery started from day 7 and was nearly complete by day 11. The MRI findings were confirmed by Evans blue staining, which showed an increase in leakage on days 1 to 7 after ICH that had nearly stopped by day 11. Quantitative analysis showed that the ratio of Evans blue concentration (ipsilateral/contralateral hemisphere) peaked at day 3 (1.19 ± 0.02), began to decline at day 7 (1.06 ± 0.03), and reached the level of sham controls (1.04 ± 0.11) on day 11 (1.0 ± 0.01, P < 0.05 vs. day 3), similar to the trend seen on T1-Gd MRI (Fig. 5c,d).
White matter injury
Both fractional anisotropy (FA; Fig. 6a, top row) and ex vivo DTI (Fig. 6b) showed white matter injury after ICH. At baseline, the FA value of the ipsilateral corpus callosum (CC) was 0.42 ± 0.02. After ICH, the FA values were significantly reduced at days 3, 7, and 28 (all P < 0.05; Fig. 6a,c). Changes in the ipsilateral internal capsule (IC) showed the same trend, with FA value decreasing from 0.55 ± 0.03 at baseline to 0.34 ± 0.06, 0.42 ± 0.03, and 0.46 ± 0.06 on days 3, 7, and 28, respectively (all P < 0.05; Fig. 6a,d). Luxol fast blue (LFB) staining provided similar results. The LFB density on brain sections in the ipsilateral CC was 0.38 ± 0.05 at baseline and then decreased to 0.30 ± 0.02, 0.33 ± 0.03, and 0.37 ± 0.08 on days 3, 7, and 28, respectively (all P < 0.05; Fig. 6e). In the ipsilateral IC, the LFB density was 0.38 ± 0.04 at baseline and then decreased to 0.29 ± 0.04, 0.34 ± 0.03, and 0.34 ± 0.02 at the corresponding time points (all P < 0.05; Fig. 6f). In both CC and IC, FA and LFB results showed significant decreases in the signal intensity at day 3 followed by a progressive repair at days 7 and 28. Neither FA nor LFB showed a significant change in the contralateral IC and CC (Fig. 6c–f). Tractography results based on the ex vivo DTI data showed disrupted white matter tracts on the ipsilateral side in a mouse brain at 28 days after ICH, which indicates that white matter injury was not recovered at that time point (Fig. 6b). Since cerebral peduncle (CP) is associated with clinical outcome in ICH patients, we quantified the FA value in CP in our model. Results from the ipsilateral hemisphere showed lower FA value in CP from day 3 to day 28 post-ICH compared with that in the sham group (0.68 ± 0.04, 0.59 ± 0.06, 0.60 ± 0.07, and 0.61 ± 0.06 for sham and days 3, 7, and 28 post-ICH, respectively; all P < 0.05; Supplementary Fig. S3a,b). We also analysed the intensity of LFB staining in the striatum around the lesion. The intensity of LFB staining on the ipsilateral side was significantly decreased on days 3 and 7 after ICH, but not on day 28, compared with that in the sham group (0.38 ± 0.04, 0.30 ± 0.02, 0.32 ± 0.03, and 0.36 ± 0.05 for sham and days 3, 7, and 28 post-ICH, respectively; P < 0.05 vs. sham at day 3 and day 7; P = 0.423 vs. sham at day 28; Supplementary Fig. S3c). Neither FA nor LFB showed a significant change in the contralateral CP or striatum (Supplementary Fig. S3b,c). Using transmission electron microscopy, we showed marked pathologic changes in myelin ultrastructure characterized by myelin breakdown or disruption at day 3 post-ICH compared with intact myelin in the sham mouse brain (Supplementary Fig. S3d).
Correlation between neurologic deficit score (NDS) and MRI signal changes
The NDS decreased from day 3 (10.2 ± 3.3) to day 7 (7.6 ± 2.3) and day 28 (3.5 ± 0.7; all P < 0.001; Fig. 7a). Correlation between NDS and lesion volume was positive, with a Pearson correlation coefficient of 0.913 (P < 0.001; Fig. 7b). The correlation between perihaematomal oedema volume in ADC and total lesion volume in T2wt MRI was positive (P < 0.001; Fig. 7c), as was the correlation between perihaematomal ADC value and total lesion volume in T2wt MRI (P = 0.016, Fig. 7d). We found a negative correlation between NDS and FA value of the ipsilateral IC on DTI MRI (P = 0.003, Fig. 7e) that disappeared after we adjusted for total lesion volume on T2 MRI. We found no correlation between NDS and FA value of the ipsilateral CP on DTI MRI (P = 0.546, Fig. 7f).
Discussion
In this study, we investigated whether noninvasive MRI could be used to evaluate the severity of grey and white matter injury and BBB disruption in a mouse model of ICH by cross-examining MRI and histologic results. Our study is novel in several ways: (1) We used multi-contrast MRI to monitor the progression of grey and white matter injury in a mouse ICH model; (2) We used ADC and T2wt MRI to identify perihaematomal vasogenic oedema; (3) We investigated the association between perihaematomal oedema and glial response or iron deposition; (4) We analysed the correlation between DTI parameters (FA in CC, IC, and CP) and neurologic deficits; and (5) We compared Gd-enhanced T1wt MRI with Evans blue extravasation for assessment of BBB breakdown.
When measuring lesion volume, we obtained results similar to those of previous studies16,22. MRI and CV staining both showed that the lesion volume decreased from day 3 to day 7, with formation of a glial scar by day 28. These results show that MRI can be used to provide quantitative estimates of haemorrhagic lesion. We also found a correlation between MRI-determined lesion volume and NDS, indicating that MRI may be useful for evaluating the outcome of ICH and efficacy of treatments.
Brain oedema is another important marker of ICH severity and injury, and a reliable prognostic indicator. The increase in perihaematomal oedema volume was previously reported to increase the odds of poor outcome on discharge23. However, in our model, we did not detect cytotoxic oedema, which would have been evident as minimum T2 changes and a large decrease in ADC signals. Instead, we detected vasogenic oedema in the perihaematomal region, indicated by high T2 and high ADC signals, findings that support those of a prior human study21. Interestingly, we detected high T2 and low ADC signals in the lesion core, observations that differed from those in the human study21. The inconsistency may stem from differences in pathophysiology of the two ICH conditions. Clinically, ICH is caused by rupture of a tiny artery, which leads to formation of a haematoma or blood clot in the lesion core, with tissues pressed and distorted in the periphery24. In contrast, in the collagenase-induced ICH model, the lesion core is composed of blood, dead tissue, and cell debris because multiple vessels rupture over time. On days 3 and 7, the high T2 signal with low ADC signal at the lesion core indicated high water content but severely restricted water diffusion caused by the presence of blood and dead tissue. In the perihaematomal region, both the ADC value and the volume of regions with high-intense ADC values were higher on day 3 than on day 7, a finding supported by the measured striatal brain water content. We defined signal changes in other brain regions of the perihaematomal area based on the unique signatures on both T2wt and ADC signals. The low T2 signal and low ADC signal at lesion edge suggests fresh gel-like haematoma or tight tissue compressed by the perihaematomal oedema. The normal T2 signal and slightly high ADC signal at oedema edge is probably associated with the indirect effect of inflammation and BBB disruption. This information is important for understanding the formation of perihaematomal vasogenic oedema because it is challenging to measure directly with histologic methods.
Activated microglia and astrocytes and infiltrating macrophages are major inflammatory cells that contribute to secondary brain damage (e.g., brain oedema) after ICH10,25. Our histologic data showed that microglia/macrophage activation peaked in the perilesional region on day 3 and then decreased with time. The ADC signal intensities also increased in the same regions and at the same time point. Synchronous changes of microglia/macrophage activation and ADC signal intensities suggest that microglia/macrophage activation may lead to the formation of perihaematomal vasogenic oedema. Clearly, the cause and effect relation between the two should be investigated in the ICH model. Contrary to our expectations, changes in the number of astrocytes did not correlate with high ADC signals in the perihaematomal region, suggesting a limited contribution of astrocytes to the formation of perihaematomal vasogenic oedema. After microglia/macrophage activation, iron deposition in the ICH brain can cause oxidative brain injury26,27. In our study, iron deposition appeared on day 3 in the perilesional brain regions with high ADC signals but did not change synchronously with ADC signals, suggesting that iron deposition may not only contribute to the perihaematomal vasogenic oedema at the acute stage (day 3) but may also negatively affect brain repair at the subacute and chronic stage (day 7 and beyond).
Brain tissue loss is common in ICH models15,17,19,28,29,30,31. Most previous MRI studies have focused only on hemispheric brain tissue loss19,28,29,30,31 rather than atrophy in different brain regions. However, histology results show that brain atrophy occurs in several brain regions, including cortex15,32 and striatum19, and results in ventricular enlargement28. On T2wt MRI, we measured the volume of striatum, cortex, hippocampus, ventricle, and hemisphere to determine which brain regions change in volume because of long-term tissue loss after ICH. Our findings were similar to those of a previous study in rats15. Both MRI and histology showed that volumetric ratios of ipsilateral striatum and cortex to the contralateral hemisphere were significantly decreased at 28 days after ICH compared with those of sham controls. Hippocampus did not exhibit this change in ratio. Iron overload33,34,35, perihaematomal oedema, and inflammation-mediated cell death19,28,29 may contribute to brain atrophy because blocking these processes was shown to attenuate brain atrophy after ICH33,34.
Assessment of secondary white matter injury after ICH with DTI has gained attention recently because it has been reported that decreased FA of the pyramidal tract in the cerebral peduncles correlates with poor functional outcome36 and that higher FA measures of the ipsilateral posterior limb of the CC predict better motor recovery in stroke-affected upper limb9. DTI/MRI has been investigated as a promising technique to evaluate functional outcome and compare treatment effects in patients with ICH37. Only a few preclinical ICH studies have used FA to estimate white matter injury and repair18,19,38. The first study showed decreased FA value at day 3 together with histologically determined neuronal degeneration, which continued to 120 days after collagenase-induced ICH in rats18. The second study, which used the blood-injection ICH model in rats, also showed a decrease in FA in the tissue near the haemorrhagic region on days 1 and 3 but did not present longer-term data38. We were the first group to show decreases in FA values of the ipsilateral CC on day 28 in a mouse collagenase-induced ICH model19. Our results here show similar changes of FA values in CC and IC, both of which are common locations measured in ICH animal studies4,15. We obtained similar findings, perhaps because pyramidal tracts comprise fibres that travel though the IC. The novel data with ex vivo DTI in our study showed marked fibre loss in the ipsilateral CC at day 28. MacLellan et al.15 reported that CC volume was decreased at 6 weeks after ICH compared with that of contralateral CC. Our results further show a negative correlation between FA value in the ipsilateral IC and NDS, though it disappeared after we adjusted for total lesion volume on T2wt MRI. The FA value in CP decreased at day 3 and then remained the same level until day 28 after ICH. A recent clinical study showed similar results39. We did not find a significant correlation between FA value in the ipsilateral CP and NDS. Interestingly, two clinical studies36,39 showed that the FA value in the ipsilateral CP early after ICH might predict motor outcome at the chronic stage. Our results differ from theirs, most likely because the CP in mouse brain is so small.
Disruption of the BBB is associated with brain oedema40 and white matter injury41,42, which contribute to secondary injury in ICH14,15,43,44. MacLellan et al.15 reported a time-dependent (12 h, 2 and 4 days) increase in BBB permeability of rats subjected to the collagenase model, but not the blood-injection model. We used the collagenase-induced ICH model and evaluated BBB permeability for a longer time course. T1-Gd MRI signal intensity increased beginning at day 1 and peaked on day 3 before decreasing at day 7 and almost disappearing at day 11. These findings, which were validated by Evans blue staining, show that BBB breakdown has begun on day 1, peaks on day 3, begins to recover on day 7, and is fully recovered by day 11. Increased BBB disruption may result in perihaematomal vasogenic oedema, which also peaks at day 3. Liu et al.40 reported the same trend of Evans blue staining in a thrombin-induced ICH model, showing that BBB is severely damaged by 1 day after thrombin injection but completely recovered by 14 days. The authors explained that Src kinases mediate both acute BBB injury and chronic BBB repair after thrombin-induced brain injury40.
Our current study shows that multimodality MRI can be used to track the dynamic progression of post-ICH injury, including haemorrhagic lesion, vasogenic brain oedema, white matter injury, and BBB breakdown, and that the results correspond with histologic findings and correlate with neurologic function. We conclude that these MRI scanning methods can be used to evaluate therapeutic interventions in preclinical ICH models and eventually humans for precision-medicine-based clinical care. Additionally, our findings indicate that increased vasogenic oedema in the perihaematomal region might be associated with microglial activation, iron toxicity, and BBB disruption.
Methods and Materials
Animals
All animal studies were conducted in accordance with National Institutes of Health guidelines and were approved by the Johns Hopkins University Animal Care and Use Committee. C57BL/6 male mice (12 months old, 32–36 g) were obtained from Charles River Laboratories (Frederick, MD) and maintained in the Johns Hopkins animal facility. All efforts were made to minimize the number of animals used and their suffering. Animal experiments were reported in accordance with the ARRIVE guidelines.
ICH mouse model
ICH was induced by injecting collagenase into the left striatum of mice according to a previously described method19,45. Briefly, mice were placed in a stereotaxic frame under anaesthesia with isoflurane. A burr hole was drilled into the skull, and type VII-S collagenase (0.075 U in 0.5 μl saline; Sigma, St. Louis, MO) was infused into the left striatum with a microinfusion pump at a constant rate of 0.1 μl/min. The needle tip was placed for haematoma induction to invade the middle of the striatum without damaging the motor cortex: 0.4 mm anterior and 2.0 mm lateral from the bregma, 3.0 mm below the skull. Sham-operated mice were infused with an equal volume of saline. Body temperature was maintained at 37 ± 0.5 °C during surgery. After surgery, mice were returned to their home cage. Vital conditions of the mice were monitored every day after ICH surgery.
Histology
Mice were anesthetized with isoflurane at day 3, 7, or 28 after ICH and perfused transcardially with phosphate-buffered saline (PBS) followed by 4% paraformaldehyde. Brains were isolated and fixed in 4% paraformaldehyde overnight and then soaked in 30% sucrose for 72 h at 4 °C. Coronal sections (25 μm) were taken at 150 μm intervals from +1.2 to −2.4 mm from the bregma. Sections were mounted onto slides and stained with CV for measurement of lesion and brain region volumes, and with LFB for measurement of myelin integrity. Perls’ staining was used to detect iron deposition. Additional adjacent sections were used for immunochemical staining as described below. Changes in brain regions were defined as (brain region volume/contralateral hemispheric volume) × 100%, as described previously15,28.
Immunohistochemistry
Before primary antibody was applied, all sections were blocked in PBS containing 3% normal goat serum and 0.2% Triton X-100 for 60 min at room temperature. Both primary and secondary antibody were diluted in PBS containing 3% normal goat serum. Based on our established protocol46, to label astrocytes and microglia/macrophages, we incubated free-floating cryosections for 12 h at 4 °C in a dilution of anti-mouse glial fibrillary acidic protein (GFAP) antibody (1:500; Sigma) and anti-rabbit Iba-1 antibody (1:500; Wako Chemicals, Richmond, VA). GFAP-positive cells were visualized with a green fluorochrome-tagged secondary antibody (Cy2, 1:1000; Invitrogen, Waltham, MA), and Iba-1–positive cells were visualized with a red fluorochrome-tagged secondary antibody (Alexa 594, 1:1000; Invitrogen) after incubation at room temperature for 1 h.
Quantification of Perls’ staining and immunofluorescence
Stained sections were examined with a Nikon Eclipse 90i fluorescence microscope (Nikon, Tokyo, Japan). We examined four randomly selected fields at 200× magnification in three sections with similar haematoma sizes in each animal. Quantifications from 12 locations were averaged and expressed as positive cells (Iba1-, GFAP-) or positive areas (Perls’ staining) with Image J software (NIH, Image J 1.48 v) as previously described19,47.
Transmission electron microscopy
At 3 days of recovery, sham and ICH mice were perfused with 2% paraformaldehyde and 2% glutaraldehyde in 0.1 M sodium cacodylate buffer, and then post-fixed in 2% osmium tetroxide with 1.6% potassium ferrocyanide in 0.1 M sodium cacodylate. Samples (at the margin of the haematoma or corresponding location) were then cut and stained en bloc with 2% uranyl acetate, dehydrated in ethanol, and embedded in eponate. Then the sections (70–90 nm) were placed on copper slot grids and stained with 2% uranyl acetate and lead citrate. Transmission electron microscopy images were captured with a Hitachi 7600 in the microscope core of Johns Hopkins University.
MRI
We performed in vivo MRI experiments on a horizontal 11.7 Tesla MR scanner (Bruker Biospin, Billerica, MA, USA) equipped with triple-axis gradient (maximum gradient strength = 74 Gauss/cm) using a volume excitation coil and a 4-channel phased array mouse head receive-only coil. Animals were anesthetized with 1–1.5% isoflurane in a mix of oxygen and air at a 1:3 ratio and placed in an animal holder (Bruker Biospin). Respiration was monitored with a pressure sensor (SAII, Stony Brook, NY, USA) and maintained at 50–60 breaths per minute by adjusting the concentration of isoflurane. Multi-slice T2wt images were collected by using a rapid acquisition with relaxation enhancement (RARE) sequence with the following parameters: echo time/repetition time = 60/3800 ms, RARE-factor = 8, four signal averages, field of view = 15 mm × 15 mm, 28 slices with 0.5 mm slice thickness, in-plane resolution of 0.08 mm × 0.08 mm, and an imaging time of 12 min. Multi-slice T1-weighted (T1wt) images were collected by using a spin echo sequence with the following parameters: echo time/repetition time = 9/250 ms, four signal averages, field of view = 15 mm × 15 mm, 10 slices with 0.5 mm slice thickness, in-plane resolution of 0.12 mm × 0.12 mm, and an imaging time of 10 min. Pre-contrast T1wt images were acquired before the injection of Gd- diethylenetriaminepentacetate (DTPA) (Magnevist, Bayer, Whippany, NJ). Post-contrast T1wt images were acquired 10 min after intraperitoneal injection of Gd-DTPA (0.2 ml/kg body weight) with normal saline. Multi-slice in vivo DTI was performed by using a four-segment diffusion-weighted echo-planar imaging sequence with the following parameters: echo time/repetition time = 24/14000 ms; one signal average; 30 diffusion directions; b = 1500 s/mm2; an in-plane resolution of 0.12 mm × 0.12 mm with a partial Fourier factor of 1.4 in the phase-encoding direction, the same field of view, slice thickness, and number of slices as the T2-weighted images. With respiratory gating, the total imaging time was approximately 30 min. All animals recovered in 5 min after imaging. We reconstructed the diffusion tensor at each pixel along with ADC and FA using the log-linear fitting method implemented in DTIStudio (http://www.mristudio.org).
In mice that had undergone collagenase-induced ICH, we manually defined the haematoma volume on days 3 and 7, residual lesion volume on day 28, and volume of striatum, hemisphere, ventricle, hippocampus, and cortex at all three time points in the T2wt images using ROIEditor (http://www.mristudio.org)19. White matter injury on day 28 post-ICH was analysed from DTI. We manually defined the ipsilateral CC from the midline to the lateral edge of the lateral ventricles in the FA images using ROIEditor and obtained the average FA value in the region for each subject.
Quantification of Evans blue leakage
A 2% solution of Evans blue in normal saline (4 ml/kg of bodyweight) was injected through the tail vein as described previously48. The stain was allowed to circulate for 2 h. Then the mice were perfused transcardially with PBS, and the brain tissue was removed and divided into right and left hemispheres. Each part of the brain was homogenized in 1 ml of PBS and then sonicated and centrifuged (30 min, 10,000 rcf, 4 °C). Evans blue stain was measured by spectrophotometry at 620 nm and quantified according to a standard curve. The results are presented as ratio of left to right hemisphere.
NDS
On days 3, 7, and 28 after surgery, an investigator blinded to group assignment evaluated the mice by an NDS system that included six domains of body symmetry, gait, climbing, circling behaviour, front limb symmetry, and compulsory circling. Each test was graded from 0 to 4, providing a total score of 0 to 24, with higher scores indicative of greater neurologic injury49,50.
Statistical analysis
All data are reported as mean ± SD. Data were analysed with Student’s t test or one-way ANOVA. Linear regression was used for correlational analysis between MRI and histological estimates of haemorrhagic lesion, brain atrophy, and oedema. A P-value < 0.05 was considered statistically significant. All statistical analyses were performed with IBM SPSS Statistics 21 (IBM, Armonk, NY).
Additional Information
How to cite this article: Yang, J. et al. Multimodality MRI assessment of grey and white matter injury and blood-brain barrier disruption after intracerebral haemorrhage in mice. Sci. Rep. 7, 40358; doi: 10.1038/srep40358 (2017).
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
Steiner, T. et al. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke 9, 840–855, doi: 10.1111/ijs.12309 (2014).
van Asch, C. J. et al. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol 9, 167–176, doi: 10.1016/s1474-4422(09)70340-0 (2010).
McDowell, M. M. et al. The role of advanced neuroimaging in intracerebral hemorrhage. Neurosurg Focus 34, E2, doi: 10.3171/2013.1.focus12409 (2013).
Matsushita, H. et al. MRI-based analysis of intracerebral hemorrhage in mice reveals relationship between hematoma expansion and the severity of symptoms. PLoS ONE 8, e67691, doi: 10.1371/journal.pone.0067691 (2013).
Kidwell, C. S., Burgess, R., Menon, R., Warach, S. & Latour, L. L. Hyperacute injury marker (HARM) in primary hemorrhage: a distinct form of CNS barrier disruption. Neurology 77, 1725–1728, doi: 10.1212/WNL.0b013e318236ef46 (2011).
Fainardi, E. et al. Temporal changes in perihematomal apparent diffusion coefficient values during the transition from acute to subacute phases in patients with spontaneous intracerebral hemorrhage. Neuroradiology 55, 145–156, doi: 10.1007/s00234-012-1093-x (2013).
Li, N. et al. Association of molecular markers with perihematomal edema and clinical outcome in intracerebral hemorrhage. Stroke 44, 658–663, doi: 10.1161/STROKEAHA.112.673590 (2013).
Yoshioka, H. et al. Diffusion tensor tractography predicts motor functional outcome in patients with spontaneous intracerebral hemorrhage. Neurosurgery 62, 97–103, discussion 103, doi: 10.1227/01.neu.0000311066.03121.b8 (2008).
Song, J. et al. DTI measures track and predict motor function outcomes in stroke rehabilitation utilizing BCI technology. Front Hum Neurosci 9, 195, doi: 10.3389/fnhum.2015.00195 (2015).
Wang, J. Preclinical and clinical research on inflammation after intracerebral hemorrhage. Prog Neurobiol 92, 463–477, doi: 10.1016/j.pneurobio.2010.08.001 (2010).
MacLellan, C. L., Silasi, G., Auriat, A. M. & Colbourne, F. Rodent models of intracerebral hemorrhage. Stroke 41, S95–98, doi: 10.1161/strokeaha.110.594457 (2010).
Kirkman, M. A., Allan, S. M. & Parry-Jones, A. R. Experimental intracerebral hemorrhage: avoiding pitfalls in translational research. J Cereb Blood Flow Metab 31, 2135–2151, doi: 10.1038/jcbfm.2011.124 (2011).
Wang, M. et al. Simultaneous detection and separation of hyperacute intracerebral hemorrhage and cerebral ischemia using amide proton transfer MRI. Magn Reson Med 74, 42–50, doi: 10.1002/mrm.25690 (2015).
Knight, R. A. et al. Temporal MRI assessment of intracerebral hemorrhage in rats. Stroke 39, 2596–2602, doi: 10.1161/strokeaha.107.506683 (2008).
MacLellan, C. L. et al. Intracerebral hemorrhage models in rat: comparing collagenase to blood infusion. J Cereb Blood Flow Metab 28, 516–525, doi: 10.1038/sj.jcbfm.9600548 (2008).
Li, M., Akhavan-Sharif, R. M., Friedlander, R. M., Du, R. & Thiex, R. What sequences on high-field MR best depict temporal resolution of experimental ICH and edema formation in mice? J Biomed Biotechnol 2012, 961461, doi: 10.1155/2012/961461 (2012).
Guan, J. et al. Nerve regeneration and functional recovery by collagen-binding brain-derived neurotrophic factor in an intracerebral hemorrhage model. Tissue Eng Part A 21, 62–74, doi: 10.1089/ten.TEA.2014.0139 (2015).
Fan, S. J. et al. Bilateral substantia nigra and pyramidal tract changes following experimental intracerebral hemorrhage: an MR diffusion tensor imaging study. NMR Biomed 26, 1089–1095, doi: 10.1002/nbm.2922 (2013).
Zhao, X. et al. Toxic role of prostaglandin E2 receptor EP1 after intracerebral hemorrhage in mice. Brain Behav Immun 46, 293–310, doi: 10.1016/j.bbi.2015.02.011 (2015).
Yang, D. et al. Statins Protect the Blood Brain Barrier Acutely after Experimental Intracerebral Hemorrhage. J Behav Brain Sci 3, 100–106 (2013).
Carhuapoma, J. R., Barker, P. B., Hanley, D. F., Wang, P. & Beauchamp, N. J. Human brain hemorrhage: quantification of perihematoma edema by use of diffusion-weighted MR imaging. AJNR Am J Neuroradiol 23, 1322–1326 (2002).
Karki, K. et al. Simvastatin and atorvastatin improve neurological outcome after experimental intracerebral hemorrhage. Stroke 40, 3384–3389, doi: 10.1161/strokeaha.108.544395 (2009).
Appelboom, G. et al. Volume-dependent effect of perihaematomal oedema on outcome for spontaneous intracerebral haemorrhages. J Neurol Neurosurg Psychiatry 84, 488–493, doi: 10.1136/jnnp-2012-303160 (2013).
Godoy, D. A., Pinero, G. R., Koller, P., Masotti, L. & Di Napoli, M. Steps to consider in the approach and management of critically ill patient with spontaneous intracerebral hemorrhage. World J Crit Care Med 4, 213–229, doi: 10.5492/wjccm.v4.i3.213 (2015).
Wu, H. et al. Dynamic changes of inflammatory markers in brain after hemorrhagic stroke in humans: a postmortem study. Brain Res 1342, 111–117, doi: 10.1016/j.brainres.2010.04.033 (2010).
Zhang, Z. et al. Distinct role of heme oxygenase-1 in early- and late-stage intracerebral hemorrhage in 12-month-old mice. J Cereb Blood Flow Metab in press, doi: 10.1177/0271678x16655814, doi: 10.1177/0271678x16655814 (2016).
Wu, G., Xi, G., Hua, Y. & Sagher, O. T2* magnetic resonance imaging sequences reflect brain tissue iron deposition following intracerebral hemorrhage. Transl Stroke Res 1, 31–34, doi: 10.1007/s12975-009-0008-6 (2010).
Wu, H. et al. PGE2 receptor agonist misoprostol protects brain against intracerebral hemorrhage in mice. Neurobiol Aging 36, 1439–1450, doi: 10.1016/j.neurobiolaging.2014.12.029 (2015).
Jiang, C. et al. Progesterone exerts neuroprotective effects and improves long-term neurologic outcome after intracerebral hemorrhage in middle-aged mice. Neurobiol Aging 42, 13–24, doi: 10.1016/j.neurobiolaging.2016.02.029 (2016).
Jin, H. et al. T2 and T2* magnetic resonance imaging sequences predict brain injury after intracerebral hemorrhage in rats. Acta Neurochir Suppl 118, 151–155, doi: 10.1007/978-3-7091-1434-6_28 (2013).
Liu, Y. et al. Quantitative gait analysis of long-term locomotion deficits in classical unilateral striatal intracerebral hemorrhage rat model. Behav Brain Res 257, 166–177, doi: 10.1016/j.bbr.2013.10.007 (2013).
Hua, Y. et al. Long-term effects of experimental intracerebral hemorrhage: the role of iron. J Neurosurg 104, 305–312, doi: 10.3171/jns.2006.104.2.305 (2006).
Wu, H., Wu, T., Xu, X., Wang, J. & Wang, J. Iron toxicity in mice with collagenase-induced intracerebral hemorrhage. J Cereb Blood Flow Metab 31, 1243–1250, doi: 10.1038/jcbfm.2010.209 (2011).
Wu, H., Wu, T., Li, M. & Wang, J. Efficacy of the lipid-soluble iron chelator 2,2′-dipyridyl against hemorrhagic brain injury. Neurobiol Dis 45, 388–394, doi: 10.1016/j.nbd.2011.08.028 (2012).
Caliaperumal, J., Ma, Y. & Colbourne, F. Intra-parenchymal ferrous iron infusion causes neuronal atrophy, cell death and progressive tissue loss: implications for intracerebral hemorrhage. Exp Neurol 237, 363–369, doi: 10.1016/j.expneurol.2012.07.001 (2012).
Kusano, Y. et al. Prediction of functional outcome in acute cerebral hemorrhage using diffusion tensor imaging at 3T: a prospective study. AJNR Am J Neuroradiol 30, 1561–1565, doi: 10.3174/ajnr.A1639 (2009).
Wu, G., Wang, L., Hong, Z., Mao, Y. & Hu, X. Effects of minimally invasive techniques for evacuation of hematoma in basal ganglia on cortical spinal tract from patients with spontaneous hemorrhage: observed by diffusion tensor imaging. Neurol Res 32, 1103–1109, doi: 10.1179/016164110x12656393665008 (2010).
Yang, F. et al. Receptor for advanced glycation end-product antagonist reduces blood-brain barrier damage after intracerebral hemorrhage. Stroke 46, 1328–1336, doi: 10.1161/strokeaha.114.008336 (2015).
Wang, D. M., Li, J., Liu, J. R. & Hu, H. Y. Diffusion tensor imaging predicts long-term motor functional outcome in patients with acute supratentorial intracranial hemorrhage. Cerebrovasc Dis 34, 199–205, doi: 10.1159/000341857 (2012).
Liu, D.-Z. et al. Blood–brain barrier breakdown and repair by Src after thrombin-induced injury. Annals of Neurology 67, 526–533, doi: 10.1002/ana.21924 (2010).
Egashira, Y., Zhao, H., Hua, Y., Keep, R. F. & Xi, G. White Matter Injury After Subarachnoid Hemorrhage: Role of Blood-Brain Barrier Disruption and Matrix Metalloproteinase-9. Stroke 46, 2909–2915, doi: 10.1161/STROKEAHA.115.010351 (2015).
Yang, Y. & Rosenberg, G. A. Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke 42, 3323–3328, doi: 10.1161/STROKEAHA.110.608257 (2011).
Chen, M. et al. The inhibitory effect of mesenchymal stem cell on blood-brain barrier disruption following intracerebral hemorrhage in rats: contribution of TSG-6. J Neuroinflammation 12, 61, doi: 10.1186/s12974-015-0284-x (2015).
Min, H. et al. TLR2-induced astrocyte MMP9 activation compromises the blood brain barrier and exacerbates intracerebral hemorrhage in animal models. Mol Brain 8, 23, doi: 10.1186/s13041-015-0116-z (2015).
Wang, J., Rogove, A. D., Tsirka, A. E. & Tsirka, S. E. Protective role of tuftsin fragment 1–3 in an animal model of intracerebral hemorrhage. Ann Neurol 54, 655–664, doi: 10.1002/ana.10750 (2003).
Han, X. et al. Inhibition of prostaglandin E2 receptor EP3 mitigates thrombin-induced brain injury. J Cereb Blood Flow Metab 36, 1059–1074, doi: 10.1177/0271678X15606462 (2016).
Wang, G. et al. Changes of ferrous iron and its transporters after intracerebral hemorrhage in rats. Int J Clin Exp Pathol 8, 10671–10679 (2015).
Wang, J. et al. Preconditioning with VEGF Enhances Angiogenic and Neuroprotective Effects of Bone Marrow Mononuclear Cell Transplantation in a Rat Model of Chronic Cerebral Hypoperfusion. Mol Neurobiol, doi: 10.1007/s12035-015-9512-8 (2015).
Wang, J. & Dore, S. Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage. Brain 130, 1643–1652, doi: 10.1093/brain/awm095 (2007).
Zhu, W. et al. Mouse models of intracerebral hemorrhage in ventricle, cortex, and hippocampus by injections of autologous blood or collagenase. PLoS ONE 9, e97423, doi: 10.1371/journal.pone.0097423 (2014).
Acknowledgements
This work was supported by grants from the American Heart Association (Grant-in-Aid, 13GRNT15730001 to J.W.; Postdoctoral Fellowship Awards, 16POST29640010 to Q.L., 15POST25090114 to X.L., and 14POST20140003 to X.H.), the National Institutes of Health (R01AT007317, R01NS078026, R01HD074593, R01NS084957) and a “Stimulating and Advancing ACCM Research (StAAR)” grant from the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medicine. We thank Claire Levine, MS, ELS, for assistance with manuscript preparation.
Author information
Authors and Affiliations
Contributions
J.Z. and J.W. designed the research; J.Y., Q.L., Z.W., C.Q., X.H., X.L., J.W., W.W., X.Z., Z.H., C.G., S.M., and J.Z. performed the research; J.R.C. commented on the manuscript; J.Y., S.M., J.Z., and J.W. wrote the paper.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Yang, J., Li, Q., Wang, Z. et al. Multimodality MRI assessment of grey and white matter injury and blood-brain barrier disruption after intracerebral haemorrhage in mice. Sci Rep 7, 40358 (2017). https://doi.org/10.1038/srep40358
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/srep40358
- Springer Nature Limited